Gamma Pharmaceuticals Inc. (PINKSHEETS: GMPM) recently announced the Company has signed an Agreement for Purchase Order Financing and an Account Purchase (Factoring) facility. Combined, the financing package enables Gamma to amplify its manufacturing and retail resources in support of increased demand for the company's products and its substantial purchase order pipeline.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
Gamma already has in place marketing programs to support sales of the Company's own branded products nationwide. Joseph Cunningham, Gamma's CFO, commented, "We have found a great group to work with and have designed a financing solution that will compress our days outstanding and provide the financial resources to ramp-up our revenue profile." Last week, Gamma announced the signing of an Agreement-in-Principal (the "Agreement") with four-time World Heavyweight Champion, Evander Holyfield. The Agreement outlines a number of commercial opportunities including the development of the "Holyfield Theory" nutritional supplements and training programs as well as cross promotions and marketing support programs for Gamma's own branded products. At present Gamma manufactures in North America, and distributes in the
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
